|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities | |
| NET INCOME (LOSS) | |
| Adjustments for: | |
| Depreciation and amortization | |
| Expected credit losses | |
| Share of profit of equity-accounted investees | |
| Gain on sales of assets | |
| Tax expense | |
| Net finance expense | |
| Share-based compensation | |
| Provisions for legal proceedings | |
| Impairment of goodwill and property, plant and equipment | |
| Net realizable value inventory adjustments | |
| DOJ (Department of Justice) and antitrust agreements | |
| Fair value adjustment of biological assets | |
| Extemporaneous Litigation | |
| Provision for avian influenza related costs | |
| Total Adjustments | |
| Changes in assets and liabilities: | |
| Trade accounts receivable | |
| Inventories | |
| Recoverable taxes | |
| Other current and non-current assets | |
| Biological assets | |
| Trade accounts payable and supply chain finance | |
| Taxes paid in installments | |
| Other current and non-current liabilities | |
| DOJ and Antitrust agreements payment | |
| Income taxes paid | |
| Changes in operating assets and liabilities | |
| Cash provided by operating activities | |
| Interest paid | |
| Interest received | |
| Net cash flows provided by operating activities | |
| Cash flows from investing activities | |
| Purchases of property, plant and equipment | |
| Purchases and disposals of intangible assets | |
| Proceeds from sale of property, plant and equipment | |
| Additional/Acquistion investments in equity-accounted investees | |
| Dividends received | |
| Related party transactions | |
| Others | |
| Cash used in investing activities | |
| Cash flows from financing activities | |
| Proceeds from loans and financing | |
| Payments of loans and financing | |
| Derivative instruments received (settled) | |
| Margin cash | |
| Dividends paid / Share premium distribution | |
| Purchase of treasury shares | |
| Payments of leasing contracts | |
| Acquisition of non-controlling interests in the subsidiary PPC | |
| Others | |
| Cash provided by (used in) financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Net change in cash and cash equivalents | |
| Cash and cash equivalents beginning of period | |
| Cash and cash equivalents at the end of period | |
| Non-cash transactions: | |
| Non-cash additions to right of use assets and lease liabilities | |
| Capitalized interest | |
| Dividends Prescribed and payable | |
| Dividend distribution through liquidation of subsidiaries |
Loading...
